These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6435982)

  • 21. Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons.
    Weerts EM; Ator NA; Kaminski BJ; Griffiths RR
    Eur J Pharmacol; 2005 Sep; 519(1-2):103-13. PubMed ID: 16129429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A late-appearing benzodiazepine-induced hypoactivity that is not reversed by a receptor antagonist.
    Lister RG; File SE
    Psychopharmacology (Berl); 1986; 88(4):520-4. PubMed ID: 3010363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lorazepam, amitriptyline, and sulpiride: withdrawal effects.
    Benazzi F
    Biol Psychiatry; 1991 Sep; 30(5):528-9. PubMed ID: 1932402
    [No Abstract]   [Full Text] [Related]  

  • 25. Lorazepam and pentobarbital discrimination: interactions with CGS 8216 and caffeine.
    Ator NA; Griffiths RR
    Eur J Pharmacol; 1985 Jan; 107(2):169-81. PubMed ID: 3979425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepine antagonist, CGS-8216, in diazepam- or pentobarbital-dependent and non-dependent rats.
    McNicholas LF; Martin WR
    Drug Alcohol Depend; 1986 Jul; 17(4):339-48. PubMed ID: 3093182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of certain calcium-channel blockers on some aspects of lorazepam-dependence in mice.
    Saad SF; Khayyal MT; Attia AS; Saad ES
    J Pharm Pharmacol; 1997 Mar; 49(3):322-8. PubMed ID: 9231355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mania precipitated by benzodiazepine withdrawal.
    Rigby J; Harvey M; Davies DR
    Acta Psychiatr Scand; 1989 Apr; 79(4):406-7. PubMed ID: 2735212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of central histaminergic system in lorazepam withdrawal syndrome in rats.
    Nath C; Gupta MB
    Pharmacol Biochem Behav; 2001 Apr; 68(4):777-82. PubMed ID: 11526976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral effects of pentobarbital, lorazepam, ethanol and chlorpromazine substitution in pentobarbital-dependent baboons.
    Lamb RJ; Griffiths RR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):47-52. PubMed ID: 8474029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons.
    Weerts EM; Goodwin AK; Griffiths RR; Brown PR; Froestl W; Jakobs C; Gibson KM
    Psychopharmacology (Berl); 2005 May; 179(3):678-87. PubMed ID: 15645222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats.
    Gupta MB; Nath C; Patnaik GK; Saxena RC
    Indian J Med Res; 1996 Jun; 103():310-4. PubMed ID: 8707372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Description of a patient with schizophrenia and coexisting megadose lorazepam dependence with slightly expressed withdrawl symptoms during drug reduction. A case report].
    Schylla A; Scisło P; Badura-Brzoza K; Pasierb N
    Wiad Lek; 2012; 65(4):243-6. PubMed ID: 23654146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of tolerance or withdrawal effects in mice after chronic administration of the non-sedating anxiolytic, CGS 9896.
    Boast CA; Gerhardt SC
    Pharmacol Biochem Behav; 1987 Mar; 26(3):601-6. PubMed ID: 3575376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination.
    Sannerud CA; Ator NA; Griffiths RR
    Drug Alcohol Depend; 1993 May; 32(3):195-208. PubMed ID: 8102330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlordiazepoxide enhances the anxiogenic action of CGS 8216 in the social interaction test: evidence for benzodiazepine withdrawal?
    File SE; Pellow S
    Pharmacol Biochem Behav; 1985 Jul; 23(1):33-6. PubMed ID: 3929278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of inhibitory effect of diphenhydramine on benzodiazepine dependence in rats.
    Nath C; Patnaik GK; Saxena RC; Gupta MB
    Indian J Physiol Pharmacol; 1997 Jan; 41(1):42-6. PubMed ID: 10225031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manic-like reaction induced by lorazepam withdrawal.
    Lapierre YD; Labelle A
    Can J Psychiatry; 1987 Nov; 32(8):697-8. PubMed ID: 3690487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol.
    Emmett-Oglesby MW; Mathis DA; Harris CM; Idemudia SO; Lal H
    J Pharmacol Exp Ther; 1988 Mar; 244(3):892-7. PubMed ID: 3150850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mania induced by lorazepam withdrawal: a report of two cases.
    Turkington D; Gill P
    J Affect Disord; 1989; 17(1):93-5. PubMed ID: 2525581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.